Hemolytic anemia secondary to alpha-interferon treatment in a patient with chronic C hepatitis.
de-la-Serna-Higuera
C
C
Gastroenterology Unit, Ramon y Cajal Hospital, Alcalá de Henares University, School of Medicine, Madrid, Spain.
Bárcena-Marugán
R
R
Sanz-de-Villalobos
E
E
D000328:Adult; D000743:Anemia, Hemolytic / Q000139:chemically induced* / Q000150:complications / Q000276:immunology*; D000998:Antiviral Agents / Q000009:adverse effects* / Q000276:immunology; D001327:Autoimmune Diseases / Q000139:chemically induced / Q000150:complications; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000628:therapy; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000276:immunology; D008297:Male
D000998:Antiviral Agents; D016898:Interferon-alpha